Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Mitchison

Showing results (51-60 of 165) with videos related to

Pageof 17
Sort By:
The American Review of Respiratory Disease|March 1, 1986
Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosisD A Mitchison, A J Nunn
Tubercle|June 1, 1987
In vitro properties of rifapentine (MDL473) relevant to its use in intermittent chemotherapy of tuberculosisJ M Dickinson, D A Mitchison
Bulletin of the International Union Against Tuberculosis|January 1, 1976
Experimental investigations of bacteriological mechanisms in short course chemotherapyJ M Dickinson, D A Mitchison
The American Review of Respiratory Disease|April 1, 1981
Experimental models to explain the high sterilizing activity of rifampin in the chemotherapy of tuberculosisJ M Dickinson, D A Mitchison
Bulletin of the International Union Against Tuberculosis|June 1, 1983
[The role of sensitivity tests in short-term chemotherapy]A R Coates, D A Mitchison
Tubercle|September 1, 1987
In vitro observations on the suitability of new rifamycins for the intermittent chemotherapy of tuberculosisJ M Dickinson, D A Mitchison
Postgraduate Medical Journal|November 1, 1971
Laboratory aspects of intermittent drug therapyD A Mitchison, J M Dickinson
Tubercle|December 1, 1970
Observations in vitro on the suitability of pyrazinamide for intermittent chemotherapy of tuberculosisJ M Dickinson, D A Mitchison
Tubercle|June 1, 1985
Activity of the combination of fludalanine and cycloserine against mycobacteria in vitroJ M Dickinson, D A Mitchison
Tubercle|September 1, 1987
In vitro activity of new rifamycins against rifampicin-resistant M. tuberculosis and MAIS-complex mycobacteriaJ M Dickinson, D A Mitchison
Pageof 17

Showing results (51-60 of 165) with videos related to

Sort By:
Pageof 17
The American Review of Respiratory Disease|March 1, 1986
Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosisD A Mitchison, A J Nunn
Tubercle|June 1, 1987
In vitro properties of rifapentine (MDL473) relevant to its use in intermittent chemotherapy of tuberculosisJ M Dickinson, D A Mitchison
Bulletin of the International Union Against Tuberculosis|January 1, 1976
Experimental investigations of bacteriological mechanisms in short course chemotherapyJ M Dickinson, D A Mitchison
The American Review of Respiratory Disease|April 1, 1981
Experimental models to explain the high sterilizing activity of rifampin in the chemotherapy of tuberculosisJ M Dickinson, D A Mitchison
Bulletin of the International Union Against Tuberculosis|June 1, 1983
[The role of sensitivity tests in short-term chemotherapy]A R Coates, D A Mitchison
Tubercle|September 1, 1987
In vitro observations on the suitability of new rifamycins for the intermittent chemotherapy of tuberculosisJ M Dickinson, D A Mitchison
Postgraduate Medical Journal|November 1, 1971
Laboratory aspects of intermittent drug therapyD A Mitchison, J M Dickinson
Tubercle|December 1, 1970
Observations in vitro on the suitability of pyrazinamide for intermittent chemotherapy of tuberculosisJ M Dickinson, D A Mitchison
Tubercle|June 1, 1985
Activity of the combination of fludalanine and cycloserine against mycobacteria in vitroJ M Dickinson, D A Mitchison
Tubercle|September 1, 1987
In vitro activity of new rifamycins against rifampicin-resistant M. tuberculosis and MAIS-complex mycobacteriaJ M Dickinson, D A Mitchison
Pageof 17